STUDY TO ASSES A DERIVATIVE HEMATOLOGIC TREATMENT IN ACUTE MUSCLE INJURIES IN ELITE ATHLETES

Phase 1

• Conditions: Acute Muscle Injury Type 3A-3B (Munich classification) or type II (Classification of Otto Chan), confirmed by radiological diagnosis and clinical agreement.; MedDRA version: 17.0 Level: PT Classification code 10028391 Term: Musculoskeletal pain System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders; Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]

• Registration Number: EUCTR2013-004140-32-ES
• Lead Sponsor: nidad de Cirugia Artroscópica

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-12-05
• Last Update Posted: 11 March 2020

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: Not specified
• Target Recruitment: 64

Inclusion Criteria

- Over 18 years.
- Acute Muscle Injury Type 3A-3B (Munich classification) or type II (Classification of Otto Chan), confirmed by radiological diagnosis and clinical agreement.
- Informed consent. Rated and signed.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 64
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- prior infiltration of corticosteroids or plasma for hamstring or quadriceps in the 6 months prior to baseline.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified